Insider · CIK 0001363812

Henderson Molly

Reports to the SEC for 5 companies · ROCHESTER, NY

sec.gov

Transactions

Companies

Filings

CIK

0001363812

Forms 4 and 5

Insider transactions

50 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2025-04-07	PHATPhathom Pharmaceuticals, Inc.S Sale	CFO and CBO	SSale	−3,678 sh	$4.55	−$16.7K	89,868
2025-02-27	PHATPhathom Pharmaceuticals, Inc.A Award	CFO and CBO	AAward	+72K sh	—	—	165,546
2025-02-27	PHATPhathom Pharmaceuticals, Inc. · Stock Option (Right to Buy)A Award	CFO and CBO	AAward	+50K sh	—	—	50,000
2025-01-21	PHATPhathom Pharmaceuticals, Inc.S Sale	CFO and CBO	SSale	−6,583 sh	$6.59	−$43.4K	93,546
2024-12-19	PHATPhathom Pharmaceuticals, Inc.S Sale	CFO and CBO	SSale	−1,291 sh	$8.00	−$10.3K	98,156
2024-07-15	PHATPhathom Pharmaceuticals, Inc.S Sale	CFO and CBO	SSale	−4,325 sh	$11.72	−$50.7K	99,447
2024-05-31	PHATPhathom Pharmaceuticals, Inc.A Award	CFO and CBO	AAward	+7,500 sh	—	—	102,763
2024-04-08	PHATPhathom Pharmaceuticals, Inc.S Sale	CFO and CBO	SSale	−3,435 sh	$11.10	−$38.1K	95,263
2024-01-19	PHATPhathom Pharmaceuticals, Inc.S Sale	CFO and CBO	SSale	−6,307 sh	$7.75	−$48.9K	98,698
2024-01-18	PHATPhathom Pharmaceuticals, Inc. · Stock Option (Right to Buy)A Award	CFO and CBO	AAward	+120K sh	—	—	120,000
2023-11-20	PHATPhathom Pharmaceuticals, Inc.S Sale	CFO and CBO	SSale	−2,127 sh	$7.24	−$15.4K	103,061
2023-11-01	PHATPhathom Pharmaceuticals, Inc.S Sale	CFO and CBO	SSale	−11.7K sh	$8.95	−$105K	105,188
2023-11-01	PHATPhathom Pharmaceuticals, Inc.S Sale	CFO and CBO	SSale	−811 sh	$7.80	−$6,325.8	116,869
2023-11-01	PHATPhathom Pharmaceuticals, Inc.A Award	CFO and CBO	AAward	+22.5K sh	—	—	117,680
2023-07-14	PHATPhathom Pharmaceuticals, Inc.A Award	CFO and CBO	AAward	+25K sh	$1.00	+$25K	95,180
2023-07-14	PHATPhathom Pharmaceuticals, Inc.A Award	CFO and CBO	AAward	+25K sh	—	—	95,180
2023-06-02	PHATPhathom Pharmaceuticals, Inc.S Sale	CFO and CBO	SSale	−1,960 sh	$11.41	−$22.4K	68,506
2023-05-22	PHATPhathom Pharmaceuticals, Inc.S Sale	CFO and CBO	SSale	−2,110 sh	$12.87	−$27.2K	70,466
2023-04-06	PHATPhathom Pharmaceuticals, Inc.S Sale	CFO and CBO	SSale	−3,439 sh	$7.27	−$25K	72,576
2023-03-01	PHATPhathom Pharmaceuticals, Inc.S Sale	CFO and CBO	SSale	−2,032 sh	$8.53	−$17.3K	76,015
2023-01-19	PHATPhathom Pharmaceuticals, Inc. · Stock Option (Right to Buy)A Award	CFO and CBO	AAward	+55K sh	—	—	55,000
2023-01-19	PHATPhathom Pharmaceuticals, Inc.A Award	CFO and CBO	AAward	+33K sh	—	—	78,047
2022-11-21	PHATPhathom Pharmaceuticals, Inc.S Sale	CFO and CBO	SSale	−2,159 sh	$9.60	−$20.7K	43,341
2022-09-01	PHATPhathom Pharmaceuticals, Inc.A Award	CFO and CBO	AAward	+7,500 sh	—	—	45,500
2022-05-19	PHATPhathom Pharmaceuticals, Inc.A Award	CFO and CBO	AAward	+12K sh	—	—	38,000
2022-05-13	PHATPhathom Pharmaceuticals, Inc.P Purchase	CFO and CBO	PPurchase	+6,000 sh	—	—	26,000
2022-04-05	PHATPhathom Pharmaceuticals, Inc.A Award	CFO and CBO	AAward	+20K sh	—	—	20,000
2022-04-05	PHATPhathom Pharmaceuticals, Inc. · Stock Option (Right to Buy)A Award	CFO and CBO	AAward	+100K sh	—	—	100,000
2022-01-31	URGNUroGen Pharma Ltd. · Stock Option (right to buy)A Award	Chief Financial Officer	AAward	+30K sh	—	—	30,000
2022-01-31	URGNUroGen Pharma Ltd.M Exercise/Conversion	Chief Financial Officer	MExercise/Conversion	+666 sh	—	—	5,579
2022-01-31	URGNUroGen Pharma Ltd. · Restricted Stock UnitsA Award	Chief Financial Officer	AAward	+7,500 sh	—	—	7,500
2022-01-31	URGNUroGen Pharma Ltd. · Restricted Stock UnitsM Exercise/Conversion	Chief Financial Officer	MExercise/Conversion	−666 sh	—	—	1,334
2022-01-31	URGNUroGen Pharma Ltd.S Sale	Chief Financial Officer	SSale	−331 sh	$7.58	−$2,508.98	5,248
2021-11-30	URGNUroGen Pharma Ltd. · Restricted Stock UnitsM Exercise/Conversion	Chief Financial Officer	MExercise/Conversion	−5,000 sh	—	—	10,000
2021-11-30	URGNUroGen Pharma Ltd.M Exercise/Conversion	Chief Financial Officer	MExercise/Conversion	+5,000 sh	—	—	7,500
2021-11-30	URGNUroGen Pharma Ltd.S Sale	Chief Financial Officer	SSale	−2,587 sh	$12.03	−$31.1K	4,913
2021-06-05	URGNUroGen Pharma Ltd. · Stock Option (right to buy)A Award	Chief Financial Officer	AAward	+15K sh	—	—	15,000
2021-05-17	URGNUroGen Pharma Ltd.P Purchase	Chief Financial Officer	PPurchase	+2,500 sh	$15.85	+$39.6K	2,500
2021-01-31	URGNUroGen Pharma Ltd. · Stock Option (right to buy)A Award	Chief Financial Officer	AAward	+6,000 sh	—	—	6,000
2021-01-31	URGNUroGen Pharma Ltd. · Restricted Stock UnitsA Award	Chief Financial Officer	AAward	+2,000 sh	—	—	2,000
2020-10-01	URGNUroGen Pharma Ltd. · Restricted Stock UnitsA Award	Chief Financial Officer	AAward	+15K sh	—	—	15,000
2020-10-01	URGNUroGen Pharma Ltd. · Stock Option (Right to Buy)A Award	Chief Financial Officer	AAward	+60K sh	—	—	60,000
2020-05-04	Ayala Pharmaceuticals, Inc.OptionsA Award	Executive Vice President & CFO	AAward	+50K sh	—	—	50,000
2019-10-24	Ayala Pharmaceuticals, Inc.OptionA Award	Executive Vice President & CFO	AAward	+25K sh	—	—	25,000
2019-04-11	Ayala Pharmaceuticals, Inc.A Award	Executive Vice President & CFO	AAward	+2,500 sh	$3.68	+$9,199.75	5,833
2019-04-09	Ayala Pharmaceuticals, Inc.A Award	Executive Vice President & CFO	AAward	+2,900 sh	$3.86	+$11.2K	2,900
2019-04-09	Ayala Pharmaceuticals, Inc.A Award	Executive Vice President & CFO	AAward	+100 sh	$3.85	+$385	100
2018-11-05	Ayala Pharmaceuticals, Inc.OptionA Award	Executive Vice President & CFO	AAward	+125K sh	—	—	125,000
2018-06-12	Ayala Pharmaceuticals, Inc.A Award	Executive Vice President & CFO	AAward	+5,000 sh	$1.89	+$9,450	5,000
2018-06-06	Ayala Pharmaceuticals, Inc.Stock OptionA Award	Executive Vice President & CFO	AAward	+250K sh	—	—	250,000

Recent filings

Accepted (ET)
Apr 84
Henderson Molly0000950170-25-052156
SEC(opens sec.gov)
Mar 34
Henderson Molly0000950170-25-031042
SEC(opens sec.gov)
Jan 234
Henderson Molly0000950170-25-008357
SEC(opens sec.gov)
Dec 204
Henderson Molly0000950170-24-139062
SEC(opens sec.gov)
Jul 174
Henderson Molly0000950170-24-084182
SEC(opens sec.gov)
May 314
Henderson Molly0000950170-24-067548
SEC(opens sec.gov)
Apr 104
Henderson Molly0000950170-24-043385
SEC(opens sec.gov)
Jan 224
Henderson Molly0001209191-24-002021
SEC(opens sec.gov)
Nov 214
Henderson Molly0001209191-23-056288
SEC(opens sec.gov)
Nov 34
Henderson Molly0001209191-23-054355
SEC(opens sec.gov)
Jul 214/A
Henderson Molly0001209191-23-043162
SEC(opens sec.gov)
Jul 174
Henderson Molly0001209191-23-042455
SEC(opens sec.gov)
Jun 54
Henderson Molly0001209191-23-034605
SEC(opens sec.gov)
May 234
Henderson Molly0001209191-23-031647
SEC(opens sec.gov)
Apr 74
Henderson Molly0001209191-23-023749
SEC(opens sec.gov)
Mar 34
Henderson Molly0001209191-23-016023
SEC(opens sec.gov)

Companies

Address

500 LINDEN OAKS

ROCHESTER, NY, US 14625